Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease thromboembolism
Phenotype C0006142|breast cancer
Sentences 8
PubMedID- 24902734 Impact of comorbidity on risk of venous thromboembolism in patients with breast cancer: a danish population-based cohort study.
PubMedID- 22859911 Risk of venous thromboembolism in women with breast cancer, with pooled incidence rates and 95% confidence intervals obtained from random effects meta-analysis.
PubMedID- 20658564 Like other serms, arzoxifene decreased vertebral fractures and invasive breast cancer while the risk of venous thromboembolic events increased.
PubMedID- 22959707 Tamoxifen-associated thromboembolism in breast cancer.
PubMedID- 23497923 Relationship between factor v leiden mutation and venous thromboembolism in patients with breast cancer treated with tamoxifen.
PubMedID- 21343938 Tamoxifen increases the risk of venous thromboembolism in women with breast cancer, but its relationship to stroke is uncertain.
PubMedID- 24452534 This positive phenomenon is observed in both healthy volunteers and in patients who run the risk of developing either atherosclerosis [18, 19] or thromboembolic disorders associated with breast cancer [20].
PubMedID- 25841596 Certain medical conditions, including hypertension, migraine, breast cancer, and risk of venous thromboembolism (vte), present contraindications.

Page: 1